Preventing Neonatal Calf Diarrhea: Making Vaccination Work in the Field

Neonatal calf diarrhea (NCD), commonly referred to as calf scours, remains one of the most significant health challenges in young calves. Beyond its impact on calf welfare, diarrhea can contribute to substantial economic losses through mortality, treatment costs, reduced growth, and impaired productivity. While vaccination is often incorporated into prevention programs, field experience suggests that vaccine performance can vary considerably between herds. 

For practicing veterinarians, the key question is often not whether vaccination should be used, but how it can be integrated effectively into a broader calf health strategy. Understanding the factors that influence vaccine success can help improve outcomes and support more informed herd-level recommendations. 

Vaccination Is Only One Part of the Prevention Plan 

Calf diarrhea is frequently considered a management-associated disease. Factors such as hygiene, environmental contamination, and colostrum management play a major role in determining disease risk. Vaccination may help strengthen existing prevention measures, but it should not be viewed as a replacement for sound management practices. 

In some situations, herds experiencing a high incidence of diarrhea may adopt vaccination as an attempt to control ongoing disease problems. However, vaccination alone may not address underlying issues that continue to expose calves to infectious challenges. As a result, veterinarians may achieve better outcomes when vaccination is implemented alongside improvements in calf management and disease prevention protocols¹. 

The Critical Importance of Passive Immunity 

One of the most important considerations in neonatal diarrhea prevention is the successful transfer of passive immunity. Failure of transfer of passive immunity or inadequate transfer of passive immunity has been associated with factors such as assisted calvings, twin births, and heifers as dams^2,3. 

This becomes particularly relevant when vaccination programs rely on maternal immunization. Many vaccination strategies focus on vaccinating pregnant cows rather than newborn calves because diarrhea often develops within the first days of life. During this period, the neonatal immune system may not respond optimally to vaccination, and maternal antibodies may interfere with vaccine-induced immunity¹. 

The effectiveness of dam vaccination therefore depends heavily on adequate colostrum intake. Even when cows are appropriately vaccinated, poor colostrum consumption can limit the transfer of protective antibodies to calves. In herds where colostrum management is inconsistent, vaccination may provide only partial benefit unless passive immunity challenges are addressed simultaneously¹. 

Matching Vaccines to Field Challenges 

Another practical consideration is the relationship between vaccine strains and circulating field pathogens. Differences between outbreak strains and vaccine strains may influence vaccine performance. In addition, diarrhea outbreaks often involve multiple pathogens, making disease control more complex than targeting a single infectious agent¹. 

Appropriate diagnostic investigation can therefore play an important role in herd-level decision-making. Identifying the pathogens involved in an outbreak may help veterinarians select products that are more relevant to the specific disease challenge present within a herd. 

This approach may be particularly important when dealing with pathogens such as enterotoxigenic Escherichia coli. Protection may depend on matching vaccines to relevant fimbrial antigens because cross-protection between different fimbrial types may not occur⁴. 

Practical Pathogen-Specific Considerations 

Commercial vaccination programs for neonatal calf diarrhea have primarily focused on bovine rotavirus (BRV), bovine coronavirus (BCV), Escherichia coli, and Salmonella. 

For BRV, strain variation has been discussed as a possible explanation for inconsistent vaccine performance. Although a predominant genotype has been identified in some regions, strain prevalence may change over time and location¹. 

BCV presents a different challenge. Antigenic variation exists, but disease expression appears to be influenced not only by viral characteristics but also by host-related factors⁵. 

In the case of Salmonella, prevention can be particularly challenging. Available commercial vaccines have shown variable outcomes under field conditions, and factors such as serovar diversity and immune response characteristics complicate vaccine development and implementation. 

Practical Clinical Insights 

When advising producers on neonatal calf diarrhea prevention, veterinarians may consider the following principles: 

• Assess passive transfer and colostrum management before relying solely on vaccination. 

• Evaluate herd-specific risk factors that may contribute to diarrhea outbreaks. 

• Use diagnostic testing to identify likely pathogens involved in disease events. 

• Select vaccination programs that align with the pathogens present in the herd. 

• Emphasize vaccination as one component of a comprehensive herd health strategy rather than a standalone intervention. 

Conclusion 

Vaccination can be a valuable tool in neonatal calf diarrhea prevention, but its success often depends on factors beyond the vaccine itself. Effective colostrum management, adequate passive immunity, appropriate diagnostics, and sound herd management practices all influence outcomes. By integrating vaccination into a broader prevention framework, veterinarians can help producers develop more robust and sustainable strategies for reducing the impact of calf scours in cow-calf operations. 

References 

1. Maier GU, Breitenbuecher J, Gomez JP, Samah F, Fausak E, Van Noord M. Vaccination for the prevention of neonatal calf diarrhea in cow-calf operations: a scoping review. Veterinary and animal science. 2022 Mar 1;15:100238. https://www.sciencedirect.com/science/article/pii/S2451943X22000096 

2. Bragg R, Macrae A, Lycett S, Burrough E, Russell G, Corbishley A. Prevalence and risk factors associated with failure of transfer of passive immunity in spring born beef suckler calves in Great Britain. Preventive veterinary medicine. 2020 Aug 1;181:105059. https://www.academia.edu/download/94551444/j.prevetmed.2020.10505920221120-1-1qdw0au.pdf 

3. Pearson JM, Pajor E, Campbell J, Levy M, Caulkett N, Windeyer MC. A randomised controlled trial investigating the effects of administering a non‐steroidal anti‐inflammatory drug to beef calves assisted at birth and risk factors associated with passive immunity, health, and growth. Veterinary record open. 2019 Jan;6(1):e000364. https://bvajournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1136/vetreco-2019-000364 

4. Dubreuil JD, Isaacson RE, Schifferli DM. Animal enterotoxigenic Escherichia coli. EcoSal Plus. 2016 Sep 8;7(1):10-128. https://pmc.ncbi.nlm.nih.gov/articles/PMC5123703/pdf/nihms780638.pdf 

5. Suzuki T, Otake Y, Uchimoto S, Hasebe A, Goto Y. Genomic characterization and phylogenetic classification of bovine coronaviruses through whole genome sequence analysis. Viruses. 2020 Feb 6;12(2):183. https://www.mdpi.com/1999-4915/12/2/183